Reduction of Nω-hydroxy-l-arginine to l-arginine by pig liver microsomes, mitochondria, and human liver microsomes

Biochemical and Biophysical Research Communications

Volumn 349, Issue 2, 2006, Pages 869-873

  Clement, Bernd ^a   Kunze, Thomas ^a   Heberling, Sabine ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

N Hydroxy l arginine; Nitric oxide; NO synthase; Reduction

Indexed keywords

ARGININE; CYTOCHROME B5; CYTOCHROME B5 REDUCTASE; CYTOCHROME P450 2D; N(G) HYDROXYARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SUPEROXIDE; DRUG DERIVATIVE; N(OMEGA) HYDROXYARGININE; N(OMEGA)-HYDROXYARGININE; OXYGEN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME MECHANISM; HUMAN; HUMAN CELL; INFLAMMATION; LIVER MICROSOME; LIVER MITOCHONDRION; MACROPHAGE ACTIVATION; MICHAELIS MENTEN KINETICS; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REDUCTION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VASODILATATION; ANIMAL; CHEMICAL MODEL; CHEMISTRY; ENZYMOLOGY; KINETICS; LIVER; METABOLISM; MITOCHONDRION; SWINE;

SUS SCROFA;

ANIMALS; ARGININE; CYTOCHROME-B(5) REDUCTASE; CYTOCHROMES B5; HUMANS; KINETICS; LIVER; MICROSOMES, LIVER; MITOCHONDRIA; MODELS, CHEMICAL; NITRIC OXIDE SYNTHASE; OXYGEN; SWINE;

EID: 33748419764     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.08.123     Document Type: Article

References (26)

1. ω-Hydroxy-l-arginine is an intermediate in the biosynthesis of nitric oxide from l-arginine. J. Biol. Chem. 266 (1991) 6259-6263
2. ω-hydroxynor-l-arginine. Biochemistry 37 (1998) 10453-10460
3. Rodriguez-Crespo I., Gerber N.C., and Ortiz de Montellano P.R. Endothelial nitric oxide synthase. Expression in Escherichia coli, spectroscopic characterization, and role of tetrahydrobiopterin in dimer formation. J. Biol. Chem. 271 (1996) 11462-11467
4. ω-hydroxyarginine to citrulline and nitrogen oxides and occurrence in NO synthases of a sequence very similar to the heme-binding sequence in P450s. Biochem. Biophys. Res. Commun. 192 (1993) 53-60
5. Mansuy D., Boucher J.-L., and Clement B. On the mechanism of nitric oxide formation upon oxidative cleavage of C{double bond, long}N(OH) bonds by NO-synthases and cytochromes P450. Biochimie 77 (1995) 661-667
6. G-hydroxy-l-arginine or hydroxylamine by superoxide ion. Int. J. Biochem. Cell Biol. 28 (1996) 1311-1318
7. ω-Hydroxy-l-arginine, a reactional intermediate in nitric oxide biosynthesis, induces cytostasis in human and murine tumor cells. Biochem. Biophys. Res. Commun. 196 (1993) 1558-1565
8. G-hydroxy-l-arginine in rats treated with bacterial lipopolysaccharide. Eur. J. Pharmacol. 275 (1995) R1-R3
9. ω-Hydroxy-l-arginine, an intermediate in the l-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase. Biochem. Biophys. Res. Commun. 203 (1994) 1614-1621
10. G-hydroxy-l-arginine during high-output NO production. Am. J. Physiol. 271 (1996) H1988-H1998
11. G-hydroxy-l-arginine in patients with rheumatoid arthritis and systemic lupus erythematosus as an index of an increased nitric oxide synthase activity. Ann. Rheum. Dis. 56 (1997) 330-332
12. Moncada S., Palmer R.M.J., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43 (1991) 109-142
13. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6 (1992) 3051-3064
14. Clement B., Schmitt S., and Zimmermann M. Enzymatic reduction of benzamidoxime to benzamidine. Arch. Pharm. 321 (1988) 955-956
15. Clement B. Reduction of N-hydroxylated compounds: amidoximes (N-hydroxyamidines) as prodrugs of amidines. Drug Metab. Rev. 34 (2002) 565-579
16. Clement B. Oxidation and reduction of nitrogen via Cyp450: importance of the reduction of genotoxic N-hydroxylated functional groups. Drug Metab.: Towards the Next Millenium (1998) 59-71
17. Clement B., Schultze-Mosgau M.-H., and Wohlers H. Cytochrome P450 dependent N-hydroxylation of a guanidine (debrisoquine), microsomal catalyzed reduction and further oxidation of the N-hydroxy-guanidine metabolite to the urea derivative. Biochem. Pharmacol. 46 (1993) 2249-2267
18. Clement B., Behrens D., Möller W., and Cashman J.R. Reduction of amphetamine hydroxylamine and other aliphatic hydroxylamines by benzamidoxime reductase and human liver microsomes. Chem. Res. Toxicol. 13 (2000) 1037-1045
19. 2-insensitive NADH-benzamidoxime reductase. J. Biol. Chem. 272 (1997) 19615-19620
20. Clement B., Demesmaeker M., and Linne S. Microsomal catalyzed N-hydroxylation of guanabenz and reduction of the N-hydroxylated metabolite: characterization of the two reactions and genotoxic potential of guanoxabenz. Chem. Res. Toxicol. 9 (1996) 682-688
21. Hovius R., Lambrechts H., Nicolay K., and deKruijff B. Improved methods to isolate and subfractionate rat liver mitochondria. Lipid composition of the inner and outer membrane. Biochim. Biophys. Acta 1021 (1990) 217-226
22. Yasukochi Y., and Masters B.S.S. Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography. J. Biol. Chem. 251 (1976) 5337-5344
23. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., and Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150 (1985) 76-85
24. Omura T., and Sato R. The carbon monoxide-binding pigment of liver microsomes, evidence for its hemoprotein nature. J. Biol. Chem. 239 (1964) 2370-2378
25. Estabrook R.W., and Werringloer J. The measurement of difference spectra: application to the cytochromes of microsomes. Methods Enzymol. 52 (1978) 212-221
26. 5 reductase. Methods Enzymol. 52 (1978) 102-108